Literature DB >> 23636964

Quantitative assessment of cardiac mechanical synchrony using equilibrium radionuclide angiography.

Harmandeep Singh1, Abhinav Singhal, Punit Sharma, Chetan D Patel, Sandeep Seth, Arun Malhotra.   

Abstract

BACKGROUND: Data on normal parameters of cardiac mechanical synchrony is limited, variable and obtained from small cohorts till date. In most studies, software used for such assessment has not been mentioned. The aim of study is to establish normal values of mechanical synchrony with equilibrium radionuclide angiography (ERNA) in a larger population using commercially available software.
METHODS: We retrospectively analysed ERNA studies of 108 patients having low pretest likelihood of coronary artery disease, no known history of cardiac disease, normal electrocardiogram and whose ERNA studies were considered normal by experienced observers. In addition, ten patients diagnosed with dilated cardiomyopathy (DCM) and having LVEF ≤ 40% underwent ERNA. Fourier first harmonic analysis of phase images was used to quantify synchrony parameters using commercially available software (XT-ERNA). Intraventricular synchrony for each ventricle was measured as the standard deviation of the LV and RV mean phase angles (SD LVmPA and SD RVmPA, respectively). Interventricular synchrony was measured as LV-RVmPA. Absolute interventricular delay was calculated as absolute difference between LV and RVmPA (without considering ± sign). All variables were expressed in milliseconds (ms) and degree (°). Intra-observer and inter-observer variabilities were assessed. Cut-off values for parameters were calculated from the normal database, and validated against patient group.
RESULTS: On phase analysis, LVmPA was observed to be 343 ± 48.5 milliseconds (174.7° ± 18.5°), SD LVmPA was 16.3 ± 5.4 milliseconds (8.2° ± 2.5°), RVmPA was 339 ± 50.4 milliseconds (171.8° ± 18.5°) and SD RVmPA was 37.3 ± 15.7 milliseconds (18.7° ± 7.2°). LV-RVmPA was observed to be 3.9 ± 21.7 milliseconds (2.9° ± 9.6°) and absolute interventricular delay was 16.3 ± 14.8 milliseconds (7.9° ± 6.1°). The cut-off values for the presence of dyssynchrony were estimated as SD LVmPA > 27.1 milliseconds (>13.2°), SD RVmPA > 68.7 milliseconds (>33.1°) and LV-RVmPA > 47.3 milliseconds (>22.1°). There was no statistically significant intra-observer or inter-observer variability. Using these cut offs, 9 patients with DCM showed the presence of left intraventricular dyssynchrony, 5 had right intraventricular dyssynchrony and 2 had interventricular dyssynchrony.
CONCLUSIONS: ERNA phase analysis offers an objective and reproducible tool to quantify cardiac mechanical synchrony using commercially available software and can be used in routine clinical practice to assess mechanical dyssynchrony.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23636964     DOI: 10.1007/s12350-013-9705-3

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  40 in total

Review 1.  Scintigraphic blood pool and phase image analysis: the optimal tool for the evaluation of resynchronization therapy.

Authors:  Elias H Botvinick
Journal:  J Nucl Cardiol       Date:  2003 Jul-Aug       Impact factor: 5.952

Review 2.  Assessment of left ventricular mechanical dyssynchrony by phase analysis of ECG-gated SPECT myocardial perfusion imaging.

Authors:  Ji Chen; Maureen M Henneman; Mark A Trimble; Jeroen J Bax; Salvador Borges-Neto; Ami E Iskandrian; Kenneth J Nichols; Ernest V Garcia
Journal:  J Nucl Cardiol       Date:  2008 Jan-Feb       Impact factor: 5.952

3.  ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons.

Authors:  Andrew E Epstein; John P DiMarco; Kenneth A Ellenbogen; N A Mark Estes; Roger A Freedman; Leonard S Gettes; A Marc Gillinov; Gabriel Gregoratos; Stephen C Hammill; David L Hayes; Mark A Hlatky; L Kristin Newby; Richard L Page; Mark H Schoenfeld; Michael J Silka; Lynne Warner Stevenson; Michael O Sweeney; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Jeffrey L Anderson; Christopher E Buller; Mark A Creager; Steven M Ettinger; David P Faxon; Jonathan L Halperin; Loren F Hiratzka; Sharon A Hunt; Harlan M Krumholz; Frederick G Kushner; Bruce W Lytle; Rick A Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel; Lynn G Tarkington; Clyde W Yancy
Journal:  Circulation       Date:  2008-05-15       Impact factor: 29.690

4.  A unique method by which to quantitate synchrony with equilibrium radionuclide angiography.

Authors:  J William O'Connell; Carole Schreck; Michael Moles; Nitish Badwar; Theresa DeMarco; Jeffrey Olgin; Byron Lee; Zian Tseng; Uday Kumar; Elias H Botvinick
Journal:  J Nucl Cardiol       Date:  2005 Jul-Aug       Impact factor: 5.952

5.  A scintiphotographic method for measuring left ventricular ejection fraction in man without cardiac catheterization.

Authors:  H W Strauss; B L Zaret; P J Hurley; T K Natarajan; B Pitt
Journal:  Am J Cardiol       Date:  1971-11       Impact factor: 2.778

6.  Impact of ischemia on left ventricular dyssynchrony by phase analysis of gated single photon emission computed tomography myocardial perfusion imaging.

Authors:  Wael Aljaroudi; Jayanth Koneru; Jaekyeong Heo; Ami E Iskandrian
Journal:  J Nucl Cardiol       Date:  2010-11-23       Impact factor: 5.952

7.  The effect of cardiac resynchronization on morbidity and mortality in heart failure.

Authors:  John G F Cleland; Jean-Claude Daubert; Erland Erdmann; Nick Freemantle; Daniel Gras; Lukas Kappenberger; Luigi Tavazzi
Journal:  N Engl J Med       Date:  2005-03-07       Impact factor: 91.245

8.  Localization of ventricular tachycardia exit site and subsequent contraction sequence and functional effects with bedside radionuclide angiography.

Authors:  Elias Botvinick; Jesse Davis; Michael Dae; John O'Connell; Norberto Schechtmann; Joseph Abbott; Fred Morady; Peter Lanzer; John Iskikian; Melvin Scheinman
Journal:  JACC Cardiovasc Imaging       Date:  2008-09

9.  Systolic improvement and mechanical resynchronization does not require electrical synchrony in the dilated failing heart with left bundle-branch block.

Authors:  Christophe Leclercq; Owen Faris; Richard Tunin; Jennifer Johnson; Ritsuchi Kato; Frank Evans; Julio Spinelli; Henry Halperin; Elliot McVeigh; David A Kass
Journal:  Circulation       Date:  2002-10-01       Impact factor: 29.690

10.  Left ventricular function and visual phase analysis with equilibrium radionuclide angiography in patients with biventricular device.

Authors:  Africa Muxí; Pilar Paredes; Lluis Mont; Francisco J Setoain; Joan Duch; Silvia Fuertes; Jaime Ortín; Ernesto Diaz-Infante; Francisca Pons
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-01-29       Impact factor: 9.236

View more
  3 in total

1.  Automated Classification of Severity in Cardiac Dyssynchrony Merging Clinical Data and Mechanical Descriptors.

Authors:  Alejandro Santos-Díaz; Raquel Valdés-Cristerna; Enrique Vallejo; Salvador Hernández; Luis Jiménez-Ángeles
Journal:  Comput Math Methods Med       Date:  2017-02-19       Impact factor: 2.238

2.  Equilibrium Radionuclide Angiography in Evaluation of Left Ventricular Mechanical Dyssynchrony in Patients with Dilated Cardiomyopathy: Comparison with Electrocardiographic Parameters and Speckle-Tracking Echocardiography.

Authors:  Abhinav Singhal; Bangkim Chandra Khangembam; Sandeep Seth; Chetan Patel
Journal:  Indian J Nucl Med       Date:  2019 Apr-Jun

Review 3.  Phase analysis of gated PET in the evaluation of mechanical ventricular synchrony: A narrative overview.

Authors:  Luis Eduardo Juarez-Orozco; Andrea Monroy-Gonzalez; Niek H J Prakken; Walter Noordzij; Juhani Knuuti; Robert A deKemp; Riemer H J A Slart
Journal:  J Nucl Cardiol       Date:  2019-03-04       Impact factor: 5.952

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.